Identification of Key Uric Acid Synthesis Pathway in a Unique Mutant Silkworm Bombyx mori Model of Parkinson's Disease

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Tabunoki, Hiroko ^a   Ono, Hiromasa ^b   Ode, Hiroaki ^a   Ishikawa, Kazuhiro ^a   Kawana, Natsuki ^a   Banno, Yutaka ^c   Shimada, Toru ^d   Nakamura, Yuki ^e   Yamamoto, Kimiko ^e   Satoh, Jun ichi ^a   Bono, Hidemasa ^b  

^a MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF GENETICS   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e NATIONAL INSTITUTE OF AGROBIOLOGICAL SCIENCES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DJ 1 PROTEIN; ROTENONE; TYROSINE 3 MONOOXYGENASE; URIC ACID; XANTHINE OXIDASE;

ANIMAL EXPERIMENT; ARTICLE; BIOSYNTHESIS; BOMBYX MORI; CONTROLLED STUDY; DJ 1 GENE; ENVIRONMENTAL STRESS; GENE EXPRESSION; HEMOLYMPH; IMMUNOHISTOCHEMISTRY; LARVA; MICROARRAY ANALYSIS; MUTANT; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION KINETICS; OXIDATIVE STRESS; PARKINSON DISEASE; PHENOTYPE; PROTEIN DEPLETION; SIGNAL TRANSDUCTION;

EID: 84880840146     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069130     Document Type: Article

References (37)

1. Devine MJ, Plun-Favreau H, Wood NW, (2011) Parkinson's disease and cancer: two wars, one front. Nat Rev Cancer 11: 812-823.
2. Hatano T, Kubo S, Sato S, Hattori N, (2009) Pathogenesis of familial Parkinson's disease: new insights based on monogenic forms of Parkinson's disease. J. Neurochem. 111: 1075-1093.
3. Montgomery EB Jr, Baker KB, Lyons K, Koller WC, (1999) Abnormal performance on the PD test battery by asymptomatic first-degree relatives. Neurology 52: 757-762.
4. Bové J, Prou D, Perier C, Przedborski S, (2005) Toxin-induced models of Parkinson's disease. NeuroRx 2: 484-494.
5. Ames BN, Cathcart R, Schwiers E, Hochstein P, (1981) Uric acid provides an antioxidant defense in humans against oxidant- and radical- caused aging and cancer: A hypothesis. Proc. Natl. Acad. Sci. USA 78: 6858-6862.
6. Church WH, Ward VL, (1994) Uric acid is reduced in the substantia nigra in Parkinson's Diseases: effect on dopamine oxidation. Brain Research Bulletin 33: 419-425.
7. Bogdanov M, Matson WR, Wang L, Matson T, Saunders-Pullman R, et al. (2008) Metabolomic profiling to develop blood biomarkers for Parkinson's disease. Brain 131: 389-396.
8. Andreadou E, Nikolaou C, Gournaras F, Rentzos M, Boufidou F, et al. (2009) Serum uric acid levels in patients with Parkinson's disease: Their relationship to treatment and disease duration. Clin. Neurol. Neurosurg. 111: 724-728.
9. Johansen KK, Wang L, Aasly JO, White LR, Matson WR, et al. (2009) Metabolomic profiling in LRRK2-related Parkinson's disease. PLoS One. 4: e7551.
10. Cipriani S, Chen X, Schwarzschild MA, (2010) Urate: a novel biomarker of Parkinson's disease risk, diagnosis and prognosis. Biomark Med. 4: 701-712.
11. Weisskopf MG, Reilly EO, Chen H, Schwarzschild MA, Ascherio A, (2007) Plasma urate and risk of Parkinson's Disease. Am. J. Epidemiol. 166: 561-567.
12. Hayashi Y, (1960) Xanthine dehydrogenase in the silkworm Bombyx mori L. Nature. 186: 1053-1054.
13. Yamada M, Inokuchi T, (1986) Conversion of uric acid to urea in the silkworm, Bombyx mori. J. Seric. Sci. Jpn. 55: 428-433.
14. Tamura T, Kanada T, Kômoto N, Yukuhiro K, Hasegawa T, et al. (1999) Rescue of oq, og and ogt mutants by injection of xanthine oxidase. J. Seric. Sci. Jpn. 68: 111-117.
15. Kômoto N, (2002) A deleted portion of one of the two xanthine dehydrogenase genes causes translucent larval skin in the oq mutant of the silkworm (Bombyx mori). Insect Biochem. Mol. Biol. 32: 591-597.
16. Kômoto N, Sezutsu H, Yukuhiro K, Banno Y, Fujii H, (2003) Mutations of the silkworm molybdenum cofactor sulfurase gene, og, cause translucent larval skin. Insect Biochem. Mol. Biol. 33: 417-427.
17. Kiuchi T, Banno Y, Katsuma S, Shimada T, (2011) Mutations in an amino acid transporter gene are responsible for sex-linked translucent larval skin of the silkworm, Bombyx mori. Insect Biochem. Mol. Biol. 41: 680-687.
18. Lüdecke B, Knappskog PM, Clayton PT, Surtees RA, Clelland JD, et al. (1996) Recessively inherited L-DOPA-responsive parkinsonism in infancy caused by a point mutation (L205P) in the tyrosine hydroxylase gene. Hum Mol Genet. 7: 1023-1028.
19. Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, et al. (1997) Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275: 90-94.
20. Kayyali US, Donaldson C, Huang H, Abdelnour R, Hassoun PM, (2001) Phosphorylation of xanthine dehydrogenase/oxidase in hypoxia. J. Biol. Chem. 276: 14359-14365.
21. Wilson MA, (2011) The role of cysteine oxidation in DJ-1 function and dysfunction. Antioxid Redox Signal. 15: 111-122.
22. Goldberg MS, Pisani A, Haburcak M, Vortherms TA, Kitada T, et al. (2005) Nigrostriatal dopaminergic deficits and hypokinesia caused by inactivation of the familial Parkinsonism-linked gene DJ-1. Neuron. 45: 489-496.
23. Kim RH, Smith PD, Aleyasin H, Hayley S, Mount MP, et al. (2005) Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc Natl Acad Sci U S A. 102: 5215-5220.
24. Zhong N, Kim CY, Rizzu P, Geula C, Porter DR, et al. (2006) DJ-1 transcriptionally up-regulates the human tyrosine hydroxylase by inhibiting the sumoylation of pyrimidine tract-binding protein-associated splicing factor. J. Biol. Chem. 281: 20940-20948.
25. Tabunoki H, Ode H, Banno Y, Katsuma S, Shimada T, et al. (2011) Bm DJ-1 is a key regulator of oxidative modification in the development of the silkworm, Bombyx mori. PLoS One. 6: e17683.
26. Kinumi T, Kimata J, Taira T, Ariga H, Niki E, (2004) Cysteine-106 of DJ-1 is the most sensitive cysteine residue to hydrogen peroxide-mediated oxidation in vivo in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 317: 722-728.
27. Zhang JY, Pan MH, Sun ZY, Huang SJ, Yu ZS, et al. (2010) The genomic underpinnings of apoptosis in the silkworm, Bombyx mori. BMC Genomics. 11: 611.
28. Tolun AA, Zhang H, Il'yasova D, Sztáray J, Young SP, et al. (2010) Allantoin in human urine quantified by ultra-performance liquid chromatography-tandem mass spectrometry. Anal. Biochem. 402: 191-193.
29. Matsuo T, Ishikawa Y, (1999) Protective role of uric acid against photooxidative stress in the silkworm, Bombyx mori (Lepidoptera: Bombycidae). Appl. Entomol. Zool. 34: 481-484.
30. Zhu TG, Wang XX, Luo WF, Zhang QL, Huang TT, et al. (2012) Protective effects of urate against 6-OHDA-induced cell injury in PC12 cells through antioxidant action. Neurosci Lett. 506: 175-179.
31. An CN, Jiang H, Wang Q, Yuan RP, Liu JM, et al. (2011) Down-regulation of DJ-1 protein in the ejaculated spermatozoa from Chinese asthenozoospermia patients. Fertil. Steril. 96: 19-23.e2.
32. Bonifati V, Rizzu P, van Baren MJ, Schaap O, Breedveld GJ, et al. (2003) Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism. Science 299: 256-259.
33. Lev N, Roncevich D, Icowicz D, Melamed E, Offen D, (2006) Role of DJ-1 in Parkinson's disease. J. Mol. Neurosci. 29: 215-25.
34. Okada M, Matsumoto K, Niki T, Taira T, Iguchi-Ariga SMM, et al. (2002) DJ-1, a target protein for an endocrine disrupter, participates in the fertilization in mice. Biol. Pharm. Bull. 25: 853-856.
35. Yoshida K, Sato Y, Yoshiike M, Nozawa S, Ariga H, et al. (2003) Immunocytochemical localization of DJ-1 in human male reproductive tissue. Mol Reprod Dev. 4: 391-397.
36. Sato H, Ishida S, Toda K, Matsuda R, Hayashi Y, et al. (2005) New approaches to mechanism analysis for drug discovery using DNA microarray data combined with KeyMolnet. Curr. Drug. Discov. Technol. 2: 89-98.
37. Huang DW, Sherman BT, Lempicki RA, (2009) Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources. Nature Protoc. 4: 44-57.